BACTERIAL STRAIN TYPING

Abstract: The invention features a method for typing the strain of a bacterial isolate, the method including the steps of: (a) providing genomic DNA from a bacterial isolate; (b) performing a polymerase chain reaction on the genomic DNA using a first and second primer to amplify genomic DNA comprising a restriction nuclease restriction site, thereby producing an amplicon having the restriction site; and (c) characterizing the amplicon of step (b), thereby typing the strain of the bacterial isolate. The invention also features a kit for distinguishing between bacterial strains comprising a set of primer pairs which, when used in a PCR reaction of genomic DNA from a sample of a bacterial isolate amplify DNA across a site for a restriction endonuclease, the amplified DNA being polymorphic between strains of the bacteria.

Description: BACTERIAL STRAIN TYPING Background ofthe Invention The invention relates to bacterial strain typing. In higher plants and animals, the identification of strains or varieties within a species is a relatively straight forward proposition, since the phenotypic characteristics ofthe organisms can be examined. However, it is often difficult to appropriately compare different isolates or strains of bacterial species, since their morphological characteristics may often be similar or the difference may only be evident in response to specific environmental conditions. Nevertheless, knowledge about the origin, relatedness, and evolution of bacterial species is an important area of inquiry, both for epidemiological purposes as well as for the understanding ofthe evolution and population dynamics of bacterial cultures. This concern becomes of particular importance when the genetics of human pathogens is considered. For example, many outbreaks of infection, particularly those that are food-borne, now affect patients nearly simultaneously in several different states or even different countries. Rapid detection of these widespread outbreaks may limit spread of disease by allowing identification and withdrawal ofthe common source of infection from the marketplace. Development of a rapid, reproducible, and easily comparable strain typing system for closely related bacterial strains such as enterohemorrhagic E. coli O157:H7 has been a particular challenge. This serotype of E. coli emerged as a highly virulent pathogen in the early 1980s and has subsequently caused several major outbreaks in the United States, Europe, and Japan, as well as a large number of sporadic infections (Kaper and O'Brien, Escherichia coli 0157 :H7 and other Shiga Toxin-Producing E. coli Strains Washington, D. C, ASM Press (1998); Griffin et al., Ann. Intern. Med. 109, 705-712 (1988)). Clinical disease in humans manifests most commonly as bloody diarrhea (hemorrhagic colitis), which can progress to the hemolytic-uremic syndrome or thrombotic thrombocytopenic purpura (Griffin and Tauxe, Epidemiol. Rev. 13,60-98 (1991)). Comparison of two or more isolates of a given bacterial species to determine if they are the same or different is a key step in many epidemiologic, phylogenetic and population studies. Delineation of isolates of specific human pathogens into distinct related strains, for example, allows epidemiologists to define outbreaks and to trace the spread of a particular strain in a population (Arbeit, Manual of Clinical Microbiology, ASM Press, pp. 190-208 (1995); Musser, Emerg. Infect. Dis. 2, 1-17 (1996)). Strains of a particular bacterial species may diverge from each other by acquisition or loss of mobile genetic elements, by point mutation, or by other genetic events such as insertions, deletions, or inversions (Arbeit, Manual of Clinical Microbiology, ASM Press, pp. 190-208 (1995)). Some bacterial species, such as Helicobacter pylori, are comprised of highly divergent strains that have undergone substantial genetic drift, and even conserved genes in such strains may differ by numerous point mutations (Salau et al, FEMS Microbiol. Lett. 161, 231-239 (1998)). On the other hand, other bacteria such as the O157:H7 serotype of Escherichia coli, are highly clonal, with individual strains containing fewer genetic differences (Wang et al, Nucleic Acids Res. 21, 5930-5933 (1993); Whittam et al, J. Infect. Dis. 157, 1124-1133 (1988)) (Wang et al., Nucleic Acids Res. 21 : 5930-5933 (1993); Whittam, Emerg. Infect. Dis. 4: 615-617. (1998)). A number of approaches, both phenotypic and genotypic, have been used to examine the relatedness of different isolates of a given bacterial species or serotype, both for epidemiologic purposes as well as to gather insights into the mechanisms of microbial evolution (Musser, Emerg. Infect. Dis. 2, 1-17 (1996); Hill et al., Clin. Microbiol. Newslett. 17, 137-142 (1995)). However, most of these systems for strain typing are limited because of lack of typeability, reproducibility, discriminatory power, ease of interpretation, or ease of performance (Arbeit, Manual of Clinical Microbiology, ASM Press, pp. 190-208 (1995)). Examples of phenotypic methods for strain typing include biotyping (carbohydrate fermentation and antimicrobial susceptibility pattern), serotyping, whole cell fatty acid profiling, phage typing, bacteriocin typing, and multilocus enzyme electrophoresis (MLEE) (Arbeit, Manual of Clinical Microbiology, ASM Press, pp. 190-208 (1995); Steele et al, Appl Environ. Microbiol. 63, 757- 760 (1997)). Of these, MLEE, based on variations in electrophoretic mobilities of enzymes encoded by housekeeping genes, is the most discriminating and has been used to study the population genetics of different bacterial species with reproducible results (Selander et al, Appl. Environ. Microbiol. 51, 873-884 (1986); Wang et al, Nucleic Acids Res. 21, 5930-5933 (1993); Pupo et a , Infect. Immun. 65: 2685-2692 (1997)). MLEE, however, is a labor intensive and expensive procedure, and may fail to distinguish alleles encoding different enzymes with the same mobility. In addition, MLEE is time-consuming, limiting its applicability in disease outbreaks, where rapidity may help limit spread ofthe disease (Arbeit, Manual of Clinical Microbiology, ASM Press, 190-208 (1995)). The other phenotypic methods often suffer from poor discriminative power and/or failure to type all strains (Arbeit, Manual of Clinical Microbiology, ASM Press, pp. 190-208 (1995)). Genotypic methods for strain typing have been used increasingly in recent years. Some ofthe earlier methods used included restriction enzyme ' analysis of plasmid and chromosomal DNA (Arbeit, Manual of Clinical Microbiology, ASM Press, pp. 190-208 (1995)), but spontaneous loss of plasmids and overlapping DNA bands led to confounding patterns, causing these procedures to be replaced with more refined molecular techniques based on Southern blot hybridization and the polymerase chain reaction (PCR) (Arbeit, Manual of Clinical Microbiology, ASM Press, pp. 190-208 (1995); Hill et al., Clin. Microbiol. Newslett. 17, 137-142 (1995); Olive and Bean J. Clin. Microbiol. 37, 1661-1669 (1999)) . Southern blot hybridization can be used to detect restriction fragment length polymorphisms (RFLP) for specific genes, and includes procedures such as ribotyping, insertion sequence (IS) typing, and virulence gene profiling (Arbeit, Manual of Clinical Microbiology, ASM Press, pp. 190-208 (1995); Olive and Bean J. Clin. Microbiol 37, 1661-1669 (1999); Mead and Griffin, Lancet 352, 1207-1212 (1998); Thompson et al, J. Clin. Microbiol. 36, 1180-1184 (1998)). Similarly, PCR-based techniques, such as restriction enzyme analysis of PCR products, PCR-based-locus-specific RFLP, repetitive extragenic palindromic element PCR (Rep-PCR), random amplified polymorphic DNA assay (RAPD), and amplified fragment length polymorphism (AFLP) have all been used for strain typing (Savelkoul et al, J. Clin. Microbiol. 37, 3083-3091 (1999); Wang et al, Nucleic Acids Res. 21, 5930-5933 (1993); Johnson and O'Bryan Clin. Diagn. Lab. Immunol. 7: 265-273 (2000); Olive and Bean, J. Clin. Microbiol. 37, 1661-1669 (1999); Arbeit, Manual of Clinical Microbiology, ASM Press, pp. 190-208 (1995); Mead and Griffin, Lancet 352, 1207-1212 (1998)). Nucleotide sequence analysis and multilocus sequence typing (MLST) are newer approaches, coupled to the rise in genomic sequencing (Olive and Bean, J. Clin. Microbiol 37, 1661-1669 (1999); Feil et al, Mol Biol Evol. 16, 1496-1502 (1999); Maiden et al, Proc. Natl. Acad. Sci. U.S.A 95, 3140-3145 (1998)). Currently, the molecular technique considered to be the most reliable and applicable system for strain typing of several bacterial species is pulsed-field gel electrophoresis (PFGE) (Tenover et al, J. Clin. Microbiol. 33, 2233-2239 (1995); Olive and Bean, J. Clin. Microbiol. 37, 1661-1669 (1999)). J-n this procedure, genomic DNA is digested with a rare cutting restriction endonuclease and PFGE is used to separate the resulting high molecular size fragments. The distinctive profiles generated enable differentiation of strains in a reproducible manner. Not all strains, however, are typeable by PFGE. The inability to type certain strains has been ascribed to methylation of restriction sites, degradation of DNA in agarose plugs, or other technical problems (Johnson et al, Appl. Environ. Microbiol. 61, 2806-2808 (1995); Murase et al, Curr. Microbiol. 38: 48-50 (1999); Harsono et al, Appl. Environ. Microbiol. 59, 3141-3144 (1993)). While all these molecular techniques may provide precise data, they are either expensive or time consuming to perform, lack sufficient discriminatory power, or require specialized equipment. Application of MLST and nucleotide sequence analysis techniques to strain typing depends on accurate identification of polymorphic sites in the genome for comparison (Olive and Bean,. J. Clin. Microbiol. 37, 1661-1669 (1999); Feil et al, Mol Biol. Evol. 16, 1496-1502 (1999)). The most important drawback of PFGE is that the comparison of results for isolates analyzed at different locations or times (and hence on different gels) requires sophisticated pattern recognition computer software (Olive and Bean,. J. Clin. Microbiol. 37, 1661-1669 (1999)). As mentioned above, however, PFGE has certain limitations as a strain typing system, including time needed for analysis and the difficulty in comparing patterns of resolved bands between isolates analyzed on different gels. PFGE has also not given any specific insights into the mechanisms by which strains of E. coli O157:H7 differ from each other or evolve over time. Although several tools are available for strain typing of bacterial isolates most of these are limited by either lack of typeability, reproducibility, discriminatory power, ease of interpretation, ease of performance, or cost effectiveness, which are the criteria for evaluating typing systems. Accordingly, a need exists in the art for the development of new approaches to bacterial strain typing. Summary ofthe Invention In general, the invention features a method for typing the strain of a bacterial isolate. The method includes the steps of: providing genomic DNA from a bacterial isolate; performing a polymerase chain reaction on the genomic DNA using a first and second primer to amplify genomic DNA including a restriction nuclease restriction site, thereby producing an amplicon having the restriction site; and characterizing the amplicon of step (b), thereby typing the strain ofthe bacterial isolate. In preferred embodiments, the method ofthe invention further includes performing a polymerase chain reaction on genomic DNA of a reference strain of a bacterial isolate using the first and second primers of step (b) to amplify genomic DNA ofthe reference strain ofthe bacterial isolate, and wherein step (c) is carried out by characterizing the amplicon ofthe reference strain ofthe bacterial isolate with the amplicon of step (b). In preferred embodiments, the reference strain ofthe bacterial isolate is E. coli O157:H7 strain 86-24. In other preferred embodiments, the method ofthe invention further includes digesting the amplicon of step (b) with a restriction nuclease that digests the amplicon at the restriction site and where step (c) is carried out by charactering the digestion products. In yet other preferred embodiments, the method ofthe invention further includes performing a polymerase chain reaction on genomic DNA of a reference strain of a bacterial isolate using the first and second primers of step (b) to amplify genomic DNA ofthe reference strain ofthe bacterial isolate and digesting the amplicon ofthe reference strain with the restriction nuclease, and where step (c) is carried out by characterizing the digestion products ofthe cleaved amplicon. One preferred reference bacterial strain used in the method is E. coli O157:H7 strain 86-24. In yet other preferred embodiments, the typing method involves selecting a restriction site that occurs infrequently in the genome ofthe bacterial isolate. The method also involves the use of a restriction nuclease such as Xb that cleaves rarely within the genome ofthe bacterial isolate. In still other preferred embodiments, the method involves generating an amplicon of step (b) that includes a PCR fragment having at least 200-400 bp. In other preferred embodiments, the method involves the use of a pathogenic bacterial strain (for example, E. cob ' Ol 57.H7). In another aspect, the invention features a method for identifying a pair of primers for typing a bacterial strain. The method, in general, includes the steps of: (a) providing genomic DNA of a bacterial strain; (b) digesting the genomic DNA ofthe bacterial strain with a restriction nuclease that cleaves a restriction site ofthe genome ofthe strain, the restriction site being flanked by a 5' and 3' region of DNA; (c) identifying a first primer that hybridizes to the 5' region flanking the restriction site and a second primer that hybridizes to the 3 ' region ofthe restriction site, wherein the first and second primers amplify genomic DNA ofthe bacterial strain having the restriction site; (d) performing a polymerase chain reaction (PCR) on the genomic DNA ofthe bacterial strain using the first and second primers of step (c) to amplify genomic DNA ofthe bacterial strain, hereby producing an amplicon; (e) providing a second genomic DNA, the second genomic DNA being from a reference bacterial strain, (f) performing a polymerase chain reaction (PCR) on the reference genomic DNA using the first and second primers of step (c) to amplify genomic DNA ofthe reference bacterial strain, thereby producing an amplicon; (i) comparing the amplicons of step (d) and step (f), wherein a difference between the amplicons of steps (d) and (f) identifies the pair of primers as a pair of primers for typing the bacterial strain. In preferred embodiments, the method further includes digesting the amplicons of step (d) and step (f) with a restriction nuclease that cleaves the amplicons at the restriction site, and further comparing the digested amplicons of step (d) and (f), wherein a difference between the products ofthe digested amplicons of steps (d) and (f) further identifies the pair of primers for typing the bacterial strain. Exemplary restriction sites useful in the method are those that occur infrequently in the genome ofthe bacterial strain. Similarly, a restriction nuclease useful in the method includes enzymes that cleave rarely within the genome ofthe bacterial strain, for example, Xbal. In preferred embodiments, the bacterial typing method involves a polymerase chain reaction that amplifies an amplicon of step (c) that includes at least 200-400 bp. The method is especially useful for analyzing pathogen bacterial strains such as E. coli O157:H7. In other preferred embodiments, the reference bacterial strain of step (e) is E. coli O157:H7 strain 86-24. In other aspects, the invention features a kit for distinguishing between bacterial strains. The kit ofthe invention includes a set of primer pairs which, when used in a PCR reaction of genomic DNA from a sample ofthe bacteria amplify DNA across a restriction site for a restriction nuclease, the amplified DNA being polymorphic between strains of the bacteria. In preferred embodiments, the primers are prepared according to the methods disclosed herein. In yet another aspect, the invention includes a bacterial strain typing profile, the typing profile produced according to any one ofthe methods described herein. In preferred embodiments, the typing profile is depicted on an agarose gel or a dot blot. The methods disclosed herein provide a straightforward means for strain typing bacteria and provide numerous advantages over current typing systems. For example, the methods ofthe invention provide a ro te for analyzing any number of bacterial isolates recovered from virtually any source, including clinical samples and food. The strain typing methods described herein are relatively simple and inexpensive to perform. Moreover, the methods can be performed in any laboratory with a thermocycler and other common laboratory materials. In addition, the methods can be performed the very day an isolate is recovered from a sample. Interpretation of typing results is also relatively straightforward as strains are typed on a characteristic profile determined by the presence or absence of amplicons. Strain typing results obtained using the disclosed methods are typically available in a few hours and are highly reproducible. Other features and advantages ofthe invention will be apparent from the following description ofthe preferred embodiments thereof, and from the claims. Brief Description ofthe Drawings Figure 1A shows a comparison of pO157 DNA from E. coli O157.H7 strain 933, representative isolates G5303 and G5323 and strain 86-24. Identical regions are shown in black and the inserts that differed between the strains, in white. The insertions in isolates G5303 and G5323 are identical, but differed from that in strain 86-24. The insertion in strain 86-24 contained an Xbal site. Fragment IK8 (in gray), amplified by primer pair IK8A/B, mapped to a region of unknown function within pO157 DNA from strain 86-24. This region occurs as a 635 bp insertion, relative to this region in strain 933. The sequence at the point of insertion is indicated and is identical in all strains shown. Figure IB shows the original primers (shown in bold) and additional primers used for further analysis ofthe polymorphisms between strains. Primers are in direct alignment with the regions in pO157 DNA from strain 86-24 used to design them. Figure 1C shows the agarose gel electrophoresis pattern of amplicons derived using the primer pairs described in Figure IB. The pattern generated depicts the polymorphism between strains 86-24 and 933 diagrammed in Figure 1A. "M" refers to molecular size marker (100 bp DNA ladder; NEB) and " +" or "-" respectively designates the presence or absence of an amplicon. Figure 2A shows a diagrammatic representation of ^bαl-restriction site- polymorphisms identified in E. coli 0157 strains that are attributable to a substitution-insertion in a lysogenic bacteriophage. Lysogenic phage DNA from E. coli O157-.H7 strain 86-24 and strain 933 were compared. Identical regions are shown in black and regions that differed between the two strains in white. Strain 933 contains a 2,091 bp substitution-insertion containing an Xbal restriction site, between the N and cl genes, in place of a 1,439 bp fragment without an Xbal site in strain 86-24. Fragment IKB3 (in gray), amplified by the primer pair IKB3A/B, mapped to the substituted region within phage 933W from strain 933. Sequence flanking the substitution-insertion is identical between the two strains. Original primers (shown in bold) and additional primers used for further analysis ofthis polymorphism between strains are depicted. Primers are in direct alignment with the regions in phage 933W used to design them. Figure 2B shows a diagrammatic representation of Xbal-xestάction site- polymorphisms identified in E. coli 0157 strains that are attributable to a chromosomal deletion-substitution. Chromosomal DΝA segments from E. coli O157:H7 isolates G5295 and G5296 and strain 933 were compared. Identical regions are shown in black and regions that differed between the strains in white. Fragment IK118 (in gray), amplified by primer pair IKJ 18A/B, mapped to a chromosomal region at an O-island-backbone junction in strain 933, and contained an Xbal restriction site in the O-island sequence. Isolates G5295 and G5296 have a deletion-substitution in this region, substituting a different segment of DΝA at the same location in place ofthe sequence containing an Xbal restriction site in strain 933. Original primers (shown in bold) and additional primers used for further analysis ofthis polymorphism between strains are depicted. Primers are in direct alignment with the regions in the DΝA from strain 933 used to design them. Figure 3 is a schematic representation showing a protocol for the design of PATS primer pairs. Genomic DΝA fragments derived from E. coli O157:H7 strains 86-24 and 933, containing an Xbal restriction site, were selectively cloned into pBluescribe. DNA was initially fragmented using Sau3AL (strain 86- 24) or Nlalll (strain 933) restriction enzymes and self-ligated. The circularized DΝA was then digested with the restriction enzyme Xbal to linearize only fragments containing an internal Xbal site. Cloning of these fragments resulted in plasmids of varying sizes that were prefixed pJJE . Insert sequences were determined and used to design PATS primer pairs, shown as divergent block arrows, which flank Xbal restriction sites in the bacterial genome. "MCS" refers to the multiple cloning site. Figure 4 shows a representative agarose gel electrophoresis pattern of amplicons generated fromE. coli O157:H7 isolates using PATS and virulence gene primer pairs. Presence or absence of amplicons was isolate specific. Lanes 1-12 show the PCR results of six isolates, obtained using PATS primer pair IK127A/B; the odd number lanes are before Xbal digestion and the even lanes, after digestion. Amplicons, when present, always digested with restriction enzyme Xbal into two fragments. Lanes 14-17 show the PCR results of a single isolate (G5299), obtained using virulence gene primer pairs, stxjF/R, stX 2 F/R, e eF/R, and hlyAF/R. These amplicons lacked an Xbal restriction site and were not digested with this enzyme (not shown). "M" refers to molecular size marker (100 bp DΝA ladder; ΝΕB). Figures 5 A and 5B show a phylogenetic analysis of E. coli O157:H7 isolates using PATS and PFGΕ data. Dendrograms were constructed using the unweighted pair-group method with arithmetic mean (XJPGMA). PFGΕ gels were analyzed using Molecular Analyst Fingerprinting Plus software (Bio-Rad) and the data was exported as a band matching table so that the two sets of data could be analyzed by the same method. Figure 5 A shows a PATS dendrogram. PATS profiles resolved the isolates into four major clusters. A genetic distance of <0J between each PATS cluster suggests a clonal lineage for these isolates. The genetic distance is indicated in increments of 0.01 below the dendrogram. Figure 5B shows a PFGΕ dendrogram. PFGΕ profiles resolved the isolates into smaller clusters and showed greater genetic distance between the isolates. JO- Figure 6 shows the PFGE patterns ofthe 44 E. coli O157:H7 isolates from 22 outbreaks. Isolate numbers are indicated above the gel. Note that isolates G5312, G5311, G5306, G5305, G5290, and G5289 could not be typed by PFGE (and are grouped together at the bottom of Fig. 5B). The lambda DNA ladder standard for PFGE applications (Bio-Rad) was used. Molecular size in kilobase (Kb) is shown to the right. Figure 7 shows multiplex PCR and DNA dot-blot assays to detect PATS polymorphisms between strains. Target-amplicons were derived from E. coli O157:H7 control strains 86-24 and 933, using each ofthe eight indicated PATS primer pairs individually. Probe-amplicons were obtained from each of a total of ten isolates, using seven ofthe eight PATS primer pairs in a multiplex PCR reaction and a separate PCR reaction with primer pair IKB5A/B. These probe- amplicons were hybridized to nylon membrane strips containing 2.5 μl of each purified target-amplicon. The hybridization patterns seen on the dot blot autoradiographs matched the corresponding PATS profiles determined above. Figure 8 shows the DNA sequence (SEQ ID NOJ) ofthe O-islands residing within the genomic sequence of E. coli O175:H7 that are not found in the sequence ofthe non-pathogenic E. coli strain K12. Detailed Description ofthe Invention The present invention is directed toward a method to efficiently and accurately type strains of bacteria, particularly pathogenic bacteria. The methodology is based on identification of genomic DNA sequences around each site for a restriction endonuclease which cuts rarely (perhaps 10 to 100 times) within the genome of an organism. PCR amplification of DNA containing the restriction cleavage site is used to determine the presence, absence, or mutation ofthe restriction site. Such changes are indicative of genetic variation, and a molecular subtyping method can be based upon the detection of such genetic variation. At least two approaches are contemplated for deriving the information for such a strain typing method. Both methods are intended to define genomic sequence information centering on the cleavage site for the restriction endonuclease. In the first approach, small DNA fragments (optimally 200-300 base pairs), each containing the restriction cleavage site, are cloned, using a method involving two different restriction endonucleases. The fragments are created by digesting the whole genomic DNA ofthe organism with a restriction endonuclease that cuts the genome many times. The small fragments are then allowed to re-circularize by self-ligation. Then the small fragments are digested using a rare restriction endonuclease, which cuts and linearizes only the fragments containing the cleavage site for that endonuclease. The linearized fragments are then sequenced to determine the sequence ofthe DNA flanking the cleavage site. The second approach is available for those organisms for which the whole genomic sequence is available. In that event, a computer search algorithm can be used to identify all sequences containing the cleavage site as well as the flanking sequences. By whichever approach is used, once the cleavage site and the flanking sequence is known, PCR primers are designed to amplify two to four hundred base pair inserts which would cross over the location ofthe restriction endonuclease cleavage site. Such PCR primers can be used on genomic DNA of samples ofthe organism to amplify the DNA ofthe organism extending across the cleavage site. Then, if desired, a simple analysis ofthe products of digestion ofthe PCR products with the rare restriction endonuclease permits strain typing ofthe organism. Alternatively, the presence or absence of a PCR product (i.e., an amplicon) is monitored. In the examples ofthe method described herein, forty Xbal restriction endonuclease sites were identified in strains of Escherichia coli O157:H7, and forty pairs of primers were designed to amplify genomic sequences stretching across those sites. A panel of strains ofthe bacterial species was then collected. Genomic DNA from the panel of 44 samples of E. coli 0151 -Ml was isolated, and the primers were used to amplify PCR products containing each ofthe forty sites for each ofthe strains in the panel. A comparison was then done to determine which primer pairs were diagnostic of variations between the strains. As it turned out, eight pairs of primers were polymorphic between the strains and could be used to distinguish strains in the collection from each other. This exercise demonstrated that it is possible to design a relatively convenient and accurate method of strain typing of bacterial pathogens based on this technique. The technique described above was used specifically to identify a method for typing strains of E. coli O157:H7, a human pathogenic bacteria. As is described in the Examples found below, the rare base cutter Xbal was utilized to design a strain typing method for E. coli O157:H7. The Xbal restriction endonuclease was used to cleave genomic DNA. In the design of the strain typing method for E. coli O157:H7, a collection of 44 strains were collected to be used to test the primer pairs designed to amplify across the Xbal sites. The forty primer pairs were used to create PCR reactions with DNA from each ofthe members ofthe panel. The presence or absence of the PCR products (i.e., amplicons) was then monitored. It was determined that eight pairs ofthe primers produced polymorphic results between the strains of O157:H7 in the collection. As is discussed below, those primers permitted identification and typing ofthe various strains of E. coli O157:H7, both for epidemiological purposes and for the study ofthe genetic evolution ofthe pathogen. These sequences are the eight pairs of primers demonstrated here to be useful for differentiating between strains of E. coli O157:H7 (Table 1A). These eight primer pairs are located on larger segments of genomic DNA which are present or absent in different stains of E. coli O157:H7. It is contemplated that any primer pairs with these larger genomic regions will work equally well to distinguish amongst the strains. In addition, the sequence ofthe larger genomic regions, referred to as O-islands, since these are islands of DNA sequence that lie within the genomic sequence of E. coli O157:H7 that are not found in the sequence of the non-pathogenic E. coli strain K12 are described in Figure 8. While this method is exemplified in the Examples described herein with the strain typing of E. coli O157:H7, it is contemplated that this method will work equally well for typing other species or sub-species of bacteria. Exemplary art-recognized bacteria include, without limitation, foodborne pathogens, non- 0157 E. coli, Salmonella species, Listeria (such as Listeria monocytogenes), Shigella species, Yersinia enter ocolitica), Vibrio species, hospital acquired pathogens (such as Enterococcus), and agents of bioterrorism (such as Bacillus anthracis). Other exemplary bacteria include the gram-positive such as Clostridium spp., Staphylococcus spp., Streptococcus spp. and the gram-negative bacteria such as Acinetobacter spp, Bacteroides spp., Bordetella pertussis, Borrelia burgdorferi, Campylobacter spp., Chlamydia trachomatis, Coxiella bumetti, Enterobacter spp., Haemophilus influenzae, Klebsiella spp., Legionella pneumophila, Mycobacterium spp., Neisseria spp., Proteus mirabilis, Pseudomonas spp., Xanthomonas spp., and Yersinia spp (such as Yersinia pestis). While the rare base cutter Xbal has been shown to work well here, it is also contemplated that this method will work equally well with other restriction endonucleases that cut genomic DNA infrequently. Other such useful art- recognized restriction nucleases include, without limitation, Avrll, Sfϊl, Pad, Notl, Sse 83871, Srfl, SgrM, BgHl, Spel, Asel, Rsrll, Smal, Sail, Apal, Cspl, SacH, Blnl, l-Ceul, Swal, and Dpήl. The following examples are intended to illustrate, not limit, the scope ofthe invention. EXAMPLE 1 Strains of Escherichia coli O157:H7 differ from each other primarily by insertions or deletions, not by single nucleotide polymorphisms The recent emergence of Escherichia coli 0151 'Ml as a human pathogen may correlate with a hypermutable state and plasticity ofthe O157 genome. The genetic events related to variations between strains of E. coli O157:H7 from human outbreaks, which differed from each other by pulsed-field gel electrophoresis patterns following Xbal digestion, were investigated. As is discussed below, this analysis demonstrated that differences between strains of O157:H7 were due to small polymorphic insertions or deletions containing Xbal sites, rather than to single nucleotide polymoφhisms in the Xbal sites themselves. The ability of E. coli O157:H7 to acquire foreign DNA sequences contributes to the plasticity of its genome (Boerlin, Cell. Mol. Life Sci. 56, 735- 741 (1999)). To determine whether the plasticity ofthe 0157 genome is due to hypermutability, a non-biased technique that determines nucleotide sequences flanking each-Ybαl restriction enzyme site in the O157:H7 genome and compares these sequences between different strains was performed. The enzyme Xbal was chosen as this is most commonly used to generate pulsed-field gel electrophoresis (PFGΕ) typing profiles currently used for differentiating isolates of E. coli O157:H7 (Harsono et al., Appl Environ. Microbiol. 59, 3141-3144 (1993)). The results ofthis analysis are described below. Results Xbal restriction site polymorphism in Ε. coli 0157 strains. A total of 40 Xbal sites were identified between the genomes of E. coli O157:H7 reference strains 86-24 and 933. Primer pairs were designed that flank each of these 40 Xbal sites and that amplify approximately 200- 400 bp sized fragments containing these sites. Control experiments were set up to test these primer pairs with colony lysates of strains 86-24 and 933, in a hotstart-touchdown PCR reaction. The presence or absence of an amplicon, as well as the presence or absence of an Xbal site within each amplicon, was assessed by PCR, Xbal digestion, and agarose gel electrophoresis. The maj ority of the primer pairs (36 of 40) amplified βj-ϊl-containing DNA fragments of equal size from both strains. However, there were four exceptions: two primer pairs derived from strain 933 failed to yield an amplicon with strain 86-24. Likewise, two primer pairs derived from strain 86-24 did not yield amplicons when strain 933 DNA was used as the template. In addition, these 40 primer pairs were used to analyze 44 E. coli 0151 -Ml isolates, two isolates each from 22 different outbreaks collected by the Centers for Disease Control and Prevention (CDC). Thirty-two ofthe 40 primer pairs produced identical results in all 44 isolates, with any particular pair generating an amplified product of identical size and containing an internal Xbal site. None ofthe 40 primer pairs generated an amplified product that lacked an Xbal site, indicating that none ofthe 44 O157.H7 isolates contained a single nucleotide polymorphism or SNP in any ofthe 40 Xbal sites. On the other hand, eight primer pairs depicted in Table 1 A (below) produced polymorphic results across the isolate set, amplifying identically sized products with an Xbal site in some isolates but failing to amplify any product in others. TABLE 1A In these latter cases, the presence or absence of an amplicon by PCR correlated with the presence or absence of a hybridizing fragment by Southern blot analysis of genomic DNAs isolated from the corresponding isolates, using control PCR amplicons as probes (data not shown). A single exception was observed with one amplicon (IK8) as a probe. This fragment hybridized to genomic DNA isolated from all 44 isolates, irrespective of whether an amplified product was obtained from any particular isolate using the IK8 A/B PCR primer pair. Further evaluation revealed that one ofthe IK8 primers (IK8B) corresponded to the 5' end ofthe IS629tnp gene, which is widely distributed over the 0157 genome (see below). The DNA sequences amplified by the 40 primer pairs were analyzed using the Genbank database (BLAST search program, NCBI) and the E. coli O157:H7 strain 933 genome sequence database (University of Wisconsin). Of the 40 O157:H7.-Ybαl-containing genome sequences amplified by the primer pairs, 18 were homologous to E. coli strain K-12 genome sequences (referred to as backbone sequences (Perna et al., Nature 409, 463-466 (2001)) and 22 were in regions ofthe O157:H7 chromosome not shared with K-12, referred to as O- islands (SΕQ ID NO.: 1) (Perna et al., Nature 409, 463-466 (2001)). The majority of these O-islands (19 of 22) occurred as distinct inserts interrupting homology to the K-12 genome at the site of insertion. Three ofthe O-islands replaced other sequences at the same site on the K-12 genome. All ofthe eight polymorphic regions that were present in some but not in other E. coli O157:H7 isolates were localized to O-islands, compared to 14 o the 32 amplified sequences that were conserved across all isolates tested (p<0.01), suggesting that the major genetic differences between O157:H7 strains occur in O-island sequences. Three ofthe eight polymoφhic regions were analyzed in more detail to gain insight into the mechanisms underlying strain differences. Additional primers were designed either from 933 or 86-24 genomic sequences to amplify regions upstream, downstream, or across the polymorphic region being evaluated. The various amplicons were purified, assessed for the presence or absence of an internal Xbal site, and sequenced. This analysis confirmed that all three regions examined, defined by primer pairs IK8A/B, IKB3A/B, and IK118A/B, were polymorphic in different O157:H7 isolates because of small insertions or deletions that contained Xbal sites, rather than because of single nucleotide polymoφhisms or SNPs in the Xbal sites themselves. For example, polymoφhism between isolates for the -ϊbβl-containing fragment amplified by J-K8A/B was a consequence of a small insertion in the virulence plasmid. Using the primer pair IK8A/B, an amplicon was obtained from E. coli O157.H7 strain 86-24 but not from strain 933. As shown in Fig. 1 A, this amplicon, referred to as IK8, specifically extended from a region of unknown function into a transposase gene (IS629tnp) located on the virulence plasmid, pO157, in strain 86-24 (Genbank Accession no. ABOl 1549) (Makino et al, DNA Res. 5, 1-9 (1998). The region of unknown function occurred as a 635 bp insertion in the DNA between the resolvase (redF) and IS629t?ψ genes in strain 86-24, compared to the sequence ofthe same region in plasmid pO157 from E. coli O157:H7 strain 933 (Fig. 1A; Genbank Accession no. AF074613) (Burland et al, Nucleic Acids Res. 26, 4196-4204 (1998)); the insertion in strain 86-24 contained an Xbal site. Primer pairs IK8C/D, IK8Ε F, and IK8G/Η were designed to amplify sections of redF and IS629tnp, and the insertion in strain 86-24 for further analysis (Fig. IB). Identical amplicons were obtained from strains 86-24 and 933 using the first two sets of primers, indicating conservation ofthe respective genes on both plasmids (Fig. 1C); these amplicons were not cleaved with.A2.aI. On the other hand, an amplicon was obtained with IK8G/H only from strain 86- 24 (Fig. 1C) and it contained an Xbal site (data not shown). The primer combination of IK8C/F was used to amplify the entire length ofthis region in both strains. The size difference in the resulting amplicons (1.2 kb from strain 86-24 and 613 bp from strain 933) confirmed the earlier observation that pO157 from strain 86-24 contained a 635 bp insertion between bp 850 and 851 of pO157 in strain 933 (Fig. 1A). BLAST search analysis revealed no homologies for the inserted sequence in strain 86-24. These same primer pairs were used to analyze four additional isolates of E. coli O157:H7, G5320, G5327, G5303, and G5323, randomly chosen from the CDC isolates that did not yield an amplicon with primer pair IK8A/B. Amplicons derived from isolates G5320 and G5327, using primer pair IK8C/F, were ofthe same size as that from strain 933 (613 bp) indicating the absence of an insertion (Fig. 1 A). Using these primers, amplicons generated from isolates G5303 and G5323 revealed a 1.3 kb insert, but this insert did not contain an internal Xbal site (Fig. 1A). Failure to obtain amplicons from isolates G5303 and G5323 with primer pairs IK8A/B and IK8G/Η showed that isolates G5303 and G5323 contained a different insertion than that in 86-24. The sequences flanking the point of insertion were, however, identical for all isolates tested, including 86-24, G5303, and G5323 (Fig. 1 A). BLAST search analysis revealed that the insert in isolates G5303 and G5323 had 99% homology to three open reading frames (ORFs), L0013, L0014, and L0015, in the LEE pafhogenicity island of E. coli O157:H7 strain 933 (Perna, N. T. et al. Infect. Immun. 66, 3810-3817 (1998)). These three ORFs comprise ISEc8 in strain 933, an insertion element similar to !SRml4 present in Rhizobium and Agrobαcterium plasmids (Schneiker et al., Curr. Microbiol. 39, 274-281 (1999)); however, the homologous insert in isolates G5303 and G5323 contained only part ofthe LOO 15 ORF and not the complete IS element. The G+C content was determined for the sequences shared between all isolates (shown as filled-in black arrows and bars in Fig. 1A; 51%), the inserted sequence in strain 86-24 (33%), and the inserted sequence in strains G5303 and G5323 (55%). The G+C content of E. coli K-12 is 50.8% (Boerlin, Cell. Mol Life Sci. 56, 735-741 (1999); Blattner et αl, Science 277, 1453-1474 (1997)). The lower G+C content ofthe insert in strain 86-24 is suggestive of a possible heterologous origin (Boerlin, Cell. Mol. Life Sci. 56, 735-741 (1999); Blattner et αl., Science 277, 1453-1474 (1997)). The higher G+C content ofthe insert in G5303 and G5323 reflects the possible origin ofthis sequence from ihe Rhizobium and Agrobαcterium genomes of high G+C (57 to 63%) composition (Nϋsslein et al., Appl. Environ. Microbiol. 64, 1283-1289 (1998)). These observations suggested that polymoφhisms between different strains of E. coli O157:H7 reflect the acquisition or loss of small, discrete segments of DNA in the genome, at least some of which may be of heterologous origin. Similar analysis of the ^bαl-containing fragment amplified by IKB3A/B linked the polymoφhism in this region to a substitution-insertion in a lysogenic bacteriophage. Using the primer pair IKB3A/B, an amplicon was obtained from E. coli O157:H7 strain 933 but not from strain 86-24. This amplicon, referred to as IKB3, was mapped to the lysogenic bacteriophage 933W in strain 933 (Genbank Accession no: AF125520) (Plunkett et al., J. Bαcteriol 181, 1767- 1778 (1999)). As shown in Fig. 2A, the IKB3 sequence overlapped a 2,091 bp insertion, containing an internal Xb l site, which was present between the anti- terminator protein (N) and repressor protein (cl) genes in phage 933 W. This insertion replaced a 1,439 bp sequence, located at exactly the same site on a similar bacteriophage inE. coli O157.H7 strain 86-24, but which lacked an-^bαl site (Fig. 2A); hence, this region was referred to as a substitution-insertion. Four additional isolates, G5290, G5325, G5296, and G5301, chosen randomly from the CDC isolates that did not yield an amplicon with primer pair JXB3A/B, were analyzed using a primer pair IKB3Ε/J that would amplify the entire length ofthis substitution-insertion (Fig. 2A). No amplicons were obtained from isolates G5325, G5296, and G5301 (Table 1), indicating that this region in these isolates is even more divergent than 86-24 from 933. This was confirmed by additional PCR reactions using primer pairs designed to amplify various segments ofthe region between IKB3E and J-KB3J, which also failed to yield amplicons from the three isolates (data not shown). In contrast, the primer pair IKB3E/J yielded an amplicon from isolate G5290 that was identical in size to that from strain 86-24 (Table 1) and lacked an Xbal site. Thus, this region has at least three variants in the E. coli O157:H7 population studied. TABLE 1 Further analysis ofthe region surrounding the sequence amplified by the primer pair IKB3A/B. Primer pairs Amplicons derived from Is. coli 0157 isolates: 86-24 933 G5290 G5325 G5296 G5301 IKB3A/B3B 193 bp a IKB3E B3J 2.6 kb b 3.2 kb a 2.6 kb b - a Amplicons contained an. Xbal restriction site. b Amplicon with a different sequence compared to strain 933 and lacking an Xbal restriction site. Analysis of a third -Xbαl-containing fragment amplified by IKl 18A B, which also differed between isolates, demonstrated a polymoφhism linked to a a deletion-substitution in the chromosome. Using the primer pair IKl 18A/B, an identical amplicon containing an Xbal site was obtained from most E. coli O157-.H7 strains/isolates tested. This amplicon, referred to as IKl 18, was mapped to a chromosomal DNA segment in E. coli O157.H7 strain 933 that extended across a junction between O-island and backbone sequences (Fig. 2B). The backbone sequence contained the putative transport gene, ypjA (Genbank Accession no. AE000350) (Perna et al, Infect. Immun. 66, 3810-3817 (1998); Rudd, Microbiol. Mol Biol. Rev. 62, 985-1019 (1998)). While this entire region, along with its Xbal site, was conserved in most ofthe E. coli O157:H7 isolates/strains tested, no amplicons were obtained from isolates G5295 and G5296 using IKl 18 A/B. E. coli O157:H7 strain 933 and isolates G5295 and G5296 were analyzed using the primer pair IKl 18C/D that amplifies across part ofthe O-island and backbone sequence into the 3' end of ypjA (Fig. 2B). A 1.5 kb amplicon containing an Xbal site was obtained from strain 933. In contrast, isolates G5295 and G5296 had replaced this 1.5 kb region with a different 1 kb of sequence, which lacked an Xbal site, did not contain any ORFs, and contained a deletion ofthe 3' end oϊypjA (Fig. 2B). Hence, this region is referred to as a deletion-substitution. The deletion-substitution in G5295 and G5296 may have been caused by the excision of a prophage in these isolates. Cryptic prophage genes have been identified in the O-island region adjacent to this O-island- backbone junction in E. coli O157:H7 strain 933 (Table 2) (Perna et al., Nature 409, 463-466 (2001)). TABLE 2 Amplicon Length of Position of Xbal Description of 0- Relation of O-island to derived from associated 0- site from one end island E. coli K-12 genome E. coli island in E. coli of O-island 0157.H7 0157.H7 strain isolates 933 B3 61,664 bp 11,088 bp Stx2-encoding Insertion prophage BP-933W 118 21,681 bp 21,637 bp Cryptic prophage CP- Replaces unrelated 933Y sequences in K-12 B5 49,798 bp 36,431 bp Cryptic prophage CP- Partial homology to 933R cryptic prophage Rac of K-12 114 44,434 bp 8,367 bp Large island adjacent Replaces unrelated to leuX; includes a sequences in K-12 putative site-specific integrase/recombinase, several IS elements, putative helicases and numerous unknowns 123 80,502 bp 35,859 bp Cryptic prophage CP- Replaces unrelated 9330 sequences in K-12 127 21,120 bp 19,318 bp Cryptic prophage CP- Insertion 933T In addition to IK8, IKB3, and IKl 18, the remaining five regions polymoφhic between isolates were also found in O-islands absent in the K-12 genome. Six ofthe 8 polymoφhic regions (JXB3, IKl 18, IKB5, IKl 14, IK123, and IKl 27) were present in strain 933 and the availability ofthe genome sequence ofthis strain allowed us to determine the properties ofthe O-islands containing these six regions (Table 2). The remaining two polymoφhic regions were present in strain 86-24, but not in the sequenced strain 933, the larger 0 genomic context therefore remained undefined. The observations concerning the differences between strains of E. coli O157:H7 are consistent with the conclusion that the high frequency of mutation among E. coli and Salmonella pathogens is due to their existence in a state of transient or permanent hypermutability, which can affect both the acquisition of 5 heterologous sequences as well as point mutations (LeClerc et al, Science, 21 A, 1208-1211 (1996)). Specifically, the presence or absence of polymoφhic Xbal sites in the 0157 genome was found to be a consequence ofthe insertion or deletion of discrete segments of DNA in the genome, rather than SNPs in individual Xbal sites. The inserted sequences containing the polymoφhic Xbal sites were quite small and usually neither encoded a functional open reading frame nor disrupted a pre-existing open reading frame. An exception was the deletion-substitution observed in isolates G5295 and G5296, which resulted in the loss of 327 bp in the 3' end o ypj A. However, this deletion did not apparently affect either the viability or pathogenicity of these isolates as they were recovered from human infection. The inserted sequences analyzed were not intact insertion sequences, transposons, or bacteriophages. However, several ofthe inserted sequences were found within O-islands that contained nearby cryptic prophage genes (Table 2), suggesting that phage-mediated events may underlie their acquisition or loss. The inserted sequences were consistently found in intergenic regions. Sequences that characterize mutational hot spots or other composition variations (van Belkum et al., Microbiol. Mol. Biol. Rev. 62, 275-293 (1998)) were not observed in the sequences flanking the insertion points, although each set of insertions occurred at exactly the same nucleotide position between strains. The analysis of O-islands in the strain 933 genome that contain these polymoφhic sequences further indicates that the major events driving evolution ofthe E. coli O157.H7 genome are not point mutational events, but rather insertions /deletions of discrete DNA sequences. Detailed Materials and Methods Described below are detailed materials and methods relating to the above-described experimental showing that strains of Escherichia coli O157:H7 differ from each other primarily by insertions or deletions, not by single nucleotide polymoφhisms. Bacteria. E. coli O157:H7 strain 86-24, streptomycin resistant and originally isolated from a human in a Washington State outbreak, was kindly provided by Dr. A. D. O'Brien. E. coli O157:H7 strain 933, a human isolate from a Michigan State outbreak, was obtained from the American Type Culture Collection (ATCC, Manassas, Na.) which has it banked as ATCC 43895. Strain 933 is the 0157 isolate that has been sequenced at the University of Wisconsin- Madison, Madison, WI. In addition, 44 isolates of E.. coli O157:H7, two each from 22 different outbreaks collected by the CDC, Atlanta, Ga., were also included in this study. The isolates from different outbreaks had different PFGΕ patterns suggesting genetic heterogeneity amongst them. The CDC numbers assigned to these isolates were as follows: G5320, G5327; G5323, G5326; G5321, G5322; G5324, G5325; G5283, G5284; G5285, G5286; G5287, G5288 G5289, G5290; G5291, G5292; G5293, G5294; G5295, G5296; G5297, G5298 G5317, G5318; G5299, G5300; G5301, G5302; G5303, G5304; G5305, G5306 G5307, G5308 (Garden); G5309, G5310 (Meat); G5311, G5312; and G5313, G5314; G5315, G5316. Forty-two ofthe 44 isolates were isolated from human clinical cases. Design of primer pairs amplifying E. coli O157:H7 Xbal sites. Genomic DΝA from E. coli 0157:H7 strains 86-24 and 933 was imtially fragmented using Sau3M (strain 86-24) or Nlalll (strain 933), followed by self- ligation. The circularized DΝA was digested with the restriction enzyme Xbal to linearize only fragments containing an internal Xbal site. These fragments were selectively cloned into pBluescribe (Stratagene USA, LaJolla, Ca.) and sequenced. Insert sequences were used to design twenty-two primer pairs flanking different Xbal restriction sites; these were prefixed IK. An additional eighteen primer pairs, with the prefix 1KB, were designed using the E. coli O157:H7 strain 933 genomic sequence being assembled at the University of Wisconsin-Madison, Madison. WI. Additional information on the design of primers is provided in Example 2 (below). PCR conditions. Colony lysates were prepared by boiling colonies suspended in sterile distilled water, followed by centrifugation at 4°C. Each E. coli O157:H7 strain template was tested with each individual primer pair in separate reactions. PCR was carried out on the GeneAmp PCR system 2400 thermal cycler (PE Biosystems, Foster City, Ca.), using 10 μl of colony lysate, 200 pmoles of each primer, 800 μM dΝTPs, lx diluted Ex Taq™ enzyme buffer, and 2.5 units of TaKaRa Ex Taq™ DNA polymerase. The hot start PCR technique was employed in which the polymerase was added only after preheating the rest of the PCR mix (Dieffenbach, C. W. & Dveksler, G. S., eds., PCR Primer -A Laboratory Manual, Cold Spring Harbor Laboratory Press, NY, 1995). This technique was used in combination with a Touchdown PCR profile (Don et al., Nucleic Acids Res. 19, 40008 (1991)). To create this profile, the regular PCR program was modified as follows: an amplification segment of 20 cycles was set where the annealing temperature started at 73°C, to touchdown at 53°C at the end of those cycles. Then, another amplification segment of 10 cycles was set, using the last annealing temperature of 53°C. Each reaction was done in triplicate. Evaluation of amplicons. Amplicons obtained by PCR were purified using the Qiaquick PCR purification kit and digested wifhXbal to confirm the presence of an Xbal site within the amplicon. Undigested and digested DNA fragments were resolved on a 4% agarose gel prepared with a combination of 3% Nusieve GTG agarose (FMC BioProducts, Rockland, Me.) and 1% agarose (Shelton Scientific Inc., Shelton, Ct.) and stained with ethidium bromide. Sequencing of purified amplicons was done at the DNA Sequencing Core Facility, Department of Molecular Biology, Massachusetts General Hospital. This facility uses ABI Prism DiTerminator cycle sequencing with AmpliTaq DNA polymerase FS and an ABI 377 DNA sequencer (Perkin-Elmer Applied Biosystems Division, Foster City, Ca.) for this puφose. Southern blots. DNA was fractionated by agarose gel electrophoresis, transferred to Hybond-N+ membranes (Amersham Pharmacia Biotech, Inc., Piscataway, NJ), UN. crosslinked to the membrane using a Stratalinker (Stratagene), and hybridized with the appropriate probe, labeled using the ECL direct nucleic acid labeling and detection system (Amersham Pharmacia). Hybridization at 42°C and post-hybridization washing of blots was done as per the ECL kit manual. Autoradiographs were prepared by exposure of processed blots to Kodak Scientific Imaging X-OMAT AR film (Eastman Kodak Company, Rochester, NY). Data analysis. Statistical analysis was performed using the EpiInfo6 (CDC) software. The significance of differences in proportions was calculated with χ 2 test, or Fisher's exact test if the size of any cell was < 5. DNA %G+C was determined using the Wisconsin Package Version 10.0, Genetics Computer Group (GCG), Madison, WI. EXAMPLE 2 Polymoφhic Amplified Typing Sequences Provide a Novel Approach to Escherichia coli O157:H7 Strain Typing As is discussed above, E. coli O157:H7 strains have been shown to differ from each other by a series of small insertions or deletions of DNA, some of which contain recognition sites for restriction enzymes. These insertions and deletions determine the complement of Xbal restriction sites in the genome of a given strain and hence detection of these β>αI-containing sequences should provide information comparable to PFGE following ^bαl digestion. Below, the potential of directly detecting these polymoφhic sequences by designing a new, simple strain typing system for E. coli O157:H7, which has been termed polymoφhic amplified typing sequences or PATS, is demonstrated. As is described above in Example 1, using two reference 0157 strains, a total of forty genomic sequences that contained Xbal sites were used to generate 40 primer pairs that flanked each individual Xbal site. These primer pairs were then used to amplify 200-400 bp fragments ofthe surrounding genomic DNAs. In particular, these primer pairs were tested with 44 0157 isolates, two each from 22 different outbreaks investigated by the Centers for Disease Control. Of the 40 primer pairs, 32 amplified identical -Xbαl-containing fragments from all 44 isolates, whereas eight produced polymoφhic results between isolates, amplifying identical J-7jαI-containing fragments from some but producing no amplicons from others. As is described in more detail below, the 44 isolates were differentiated into 14 groups based on which ofthe eight polymoφhic amplicons were detected; phylogenetic analysis divided the isolates into four major clusters. PATS correctly identified 21 of 22 outbreak pairs as identical or highly related, compared to 14 of 22 identified as such by PFGE; PATS also was able to type isolates from three outbreaks that were untypeable by PFGE. However, PATS was less sensitive than PFGE in discriminating between outbreaks. These data demonstrated that PATS provided a simple procedure for strain typing not only 0157, but also other bacteria. Results PATS primer pairs. PATS primer pairs to 40 Xbal sites (and flanking DNA sequences) between the genomes of E. coli O157:H7 strains 86-24 and 933 were prepared as follows. (A) Using Sαt.3AI-digested, genomic fragments of E. coli O157:H7 strain 86-24 (Fig. 3): Recombinant plasmids pIKl-100 containing E. coli O157:H7 strain 86-24 inserts, derived by digestion of genomic DNA by Sαw3AI and recovery of inserts containing individual Xbal sites were constructed (Fig. 3). Duplicates among these were eliminated by Southern blot analysis prior to sequencing (data not shown) and insert sequences were used to design primer pairs that flanked the genomic Xbal restriction sites. Of these 100 plasmids, twelve were found to possess distinct, non-overlapping insert sequences. Primer pairs IKl A B, IK2A/B, IK8A/B, IK10A/B, IK12A B, IK18A/B, IK23A/B, IK25A/B, IK38A/B, IK39A/B, JX51A/B, and HC56A/B were derived from these insert sequences. Numbers used to label primer pairs match the pIK plasmid used to design them. (B) Using αiπ-digested genomic fragments of E. coli O157:H7 strain 933 (Fig. 3): Similar to the construction of plasmids pIKl-100, plasmids pIKlOl-150 contained inserts from E. coli O157:H7 strain 933, derived by digestion of genomic DNA by NlaUl and recovery of inserts containing individual Xbal sites (Fig. 3). These 50 plasmids were analyzed as above and ten of these were found to contain unique insert sequences. Primer pairs IKl 11 A B, IK114A B, IK116A B, IK117A/B, JK118A/B, IK123A/B, JX127A/B, K131A/B, IK142A B, and IK148A B were derived from these insert sequences. (C) Using the genome sequence of E. coli O157:H7 strain 933: Ofthe DNA fragments containing Xbal sites identified by sequencing ofthe E. coli O157:H7 strain 933, 18 did not match sequences already identified in pJ-Kl-150. Sequences of these 18 fragments were used to design 18 additional PATS primer pairs designated with 1KB numbers (TKB1 A B, IKB3A B, IKB4A/B, IKB5A/B, IKB6A/B, IKB7A/B, IKB8A B, IKB9A B, IKBIOA/B, IKB13A/B, KB14A/B, IKB15A/B, IKB16A/B, KB17A/B, JKB18A/B, IKB19A/B, IKB20A/B, and IKB21 A/B), thereby increasing the overall total of PATS primer pairs to forty. PATS primer pairs amplify sequences in the E. coli O157:H7 genome containing Xbal restriction sites. Control PCR experiments were set up to test the PATS primer pairs, using colony lysates and genomic DNA of E. coli O157:H7 strains 86-24 and 933 as templates. The PATS primer pairs amplified DNA fragments (one amplicon per primer pair) containing a single Xbal restriction site, from templates corresponding to the E. coli O157:H7 strain used to design them. Identical results were obtained with both the lysate and purified DNA templates (data not shown). The majority ofthe PATS primer pairs amplified ^ ϊbαl-containing DNA fragments of identical size from both control strains. However, there were four exceptions. PATS primer pairs IKl 14A B and IKB3A B, derived from strain 933, failed to yield an amplicon with strain 86-24. Likewise, PATS primer pairs IK8A/B and IK25A/B, derived from strain 86-24, failed to amplify when strain 933 DNA was used as the template. Thus, the PATS primer pairs were able to establish a discriminating profile between the two strains, based on the presence or absence of amplicons. PATS primers provide a strain typing system for E. coli O157:H7. The ability ofthe 40 PATS primer pairs to discriminate E. coli O157:H7 isolates in a reproducible manner was assessed. To enhance the profile for each isolate being typed, primer pairs derived from four virulence genes (stx \ , stX 2 , eαe, and hlyA), often (but not always) found in E. coli O157:H7, were also included in the PATS typing system. Based on results obtained with the control strains, colony lysates were used as templates for PCR and the presence/absence of amplicons, as well as the presence/absence of an Xbal site within each amplicon, was assessed by agarose gel electrophoresis. Results were recorded using the digits 0, 1, or 2, indicating the absence of an amplicon, the presence of an amplicon without an Xbal site, and the presence of an amplicon with an Xbal site, respectively. Forty-four isolates of E. coli O157:H7, two each from 22 different outbreaks (Table 3), were analyzed using this typing system. The presence or absence of an Xbal site within each amplicon was assessed by agarose gel electrophoresis. A representative agarose gel electrophoresis pattern of undigested and -¥bαl-digested amplicons obtained from some ofthe isolates is shown in Figure 4. All amplicons derived using the PATS primer pairs had a score of 0 or 2; i.e. all isolates that had an amplicon with a given primer pair always had an internal Xbal site in the amplicon, as seen originally in the control strain used to design the PATS primers. Amplicons obtained with the virulence gene primer pairs had a score 0 or 1. Based on the score assigned to each amplicon obtained from every isolate-primer pair combination tested, the 44 E. coli O157:H7 isolates were differentiated into 14 PATS types, arbitrarily designated A through N (Table 4). The most common PATS types were Ε and G. The reproducibility ofthis typing system was demonstrated by the consistency of profiles obtained in three separate analyses ofthe 44 outbreak isolates. TABLE 3 Summary of is. coli 0157:H7 isolates used in this study Isolates Description/Source Outbreak Outbreak Year number location 86-24 Human; Sm r strain; Dr. A. D. NA NA NA O'Brien, personal communication 933 Human; American Type Culture NA NA NA Collection From the Center for Disease Control : G5320, G5327 Human 1 Michigan 1982 G5323, G5326 Human 2 Oregon 1982 G5321, G5322 Human 3 Nebraska 1984 G5324, G5325 Human 4 North Carolina 1984 G5283, G5284 Human 5 North Carolina 1986 G5285, G5286 Human 6 Washington 1986 G5287, G5288 Human 7 Washington 1986 G5289, G5290 Human 8 Washington 1986 G5291, G5292 Human 9 Utah 1987 G5293, G5294 Human 10 Wisconsin 1988 G5295, G5296 Human 11 Minnesota 1988 G5297, G5298 Human 12 Minnesota 1988 G5317, G5318 Human 13 Missouri 1990 G5299, G5300 Human 14 Idaho 1990 G5301, G5302 Human 15 Montana 1991 G5303, G5304 Human 16 Massachusetts 1991 G5305, G5306 Human 17 Nevada 1992 G5307, G5308 Human, Garden 18 Maine 1992 G5309, G5310 Human, Meat 19 Washington 1993 G5311, G5312 Human 20 Oregon 1993 G5313, G5314 Human 21 Oregon 1993 G5315, G5316 Human 22 Oregon 1993 "NA, not applicable. The typing patterns observed for these isolates and control strains of E. coli O157:H7 were further verified via Southern blot analysis (data not shown). The presence or absence of an amplicon by PCR corresponded with the presence or absence of a hybridizing fragment in genomic DNA, using the control PCR amplicon as a probe (data not shown). A single exception was observed when the IK8A/B amplicon was used as a probe. This fragment hybridized to DNA from all strains by Southern blot, irrespective ofthe PCR result. As is described in Example 1, the IK8A/B amplicon partially overlaps the IS629t«p gene, which is widely distributed over the 0157 genome. Xbal sites that differ between different O157:H7 strains are located on inserted or deleted 0157-specific sequences. The only differences in the PATS profiles between strains occurred with eight ofthe 40 PATS primer pairs, which amplified regions ofthe E. coli O157:H7 genome that were polymoφhic between strains (Tables 4 and 5); that is, these eight primer pairs failed to yield an amplification product in some ofthe strains tested. These eight PATS primer pairs included IK8A/B, IK25A/B, IK114A/B, IK118A/B, IK123A/B, IK127A/B, IKB3A/B, and D B5A/B. Regions amplified by the remaining 32 PATS primer pairs were conserved across all strains tested (Tables 4 and 5); that is, for each of these 32 primer pairs, all strains tested had an identically sized PCR product with a conserved Xbal site. As is described in Example 1, the eight PATS primer pairs that yielded polymoφhic results between strains, amplified regions of DNA that were inserted or deleted between strains and were all localized in so-called O- island sequences, which are specific to the 0157 genome and not found in E. coli K-12 (Table 4). TABLE 4 i?. cσtt 0157 genomic regions amplified by the 40 PATS primer pairs Regions conserved across all Regions polymorphic between strains strains Primer Pair Location in E. coli Primer Pair Location in E. coli 0157 Ol 57 genome genome ΠCIA/B -Backbone 3 IK8A/B -O-island IK2A B -Backbone IK25A B -O-island IKIOA/B -Backbone LK114A/B -O-island IK12A/B -Backbone H 118A/B -O-island IK18A/B -0-island b IK123A/B -O-island IK23A B -Backbone IK127A/B -O-island IK38A/B -Backbone IKB3A/B -O-island LK39A B -O-island IKB5A/B -O-island K51A B -Backbone IK56A/B -Backbone IKlllA/B -O-island IK116A/B -Backbone K117A/B -Backbone K-131A B -Backbone IK142A/B -O-island IK148A/B -Backbone ΓKBIA/B -O-island IKB4A/B -Backbone IKB6A B -O-island IKB7A/B -O-island IKB8A/B -O-island IKB9A/B -O-island IKB10A B -O-island IKB13A/B -O-island KB14A-1/B-1 -Backbone IKB15A/B -O-island KB16A/B -Backbone KB17A/B -O-island IKB18A/B -Backbone KB19A/B -Backbone IKB20A/B -O-island KB21A/B -Backbone Backbone, DNA sequences homologous to E. coli K-12 genome. b O-island, DNA sequences unique to E. coli 0157 genome. TABLE 5 PATS profiles of E. coli O157:H7 isolates. Control 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 1 1 1 E. coli 0157.H7 strain 86-24 Control 2 2 0 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 E. coli 0157:H7 strain 933 A 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 1 1 1 G5289, G5290, G5311, G5312 B 2 2 0 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 G5320, G5327 C 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 G5317, G5324, G5325 D 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 1 1 1 G5283, G5284, G5307, • G5308 E 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 G5285, G5286, G5287, G5293, G5294, G5300, G5315, G5321, G5322, G5326 F 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 G5288, G5299 G 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 G5291, G5292, G5297, G5298, G5301, G5302, G5309, G5310, G5316 H 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 0 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 1 1 1 G5295, G5296 I 2 2 0 2 2 2 2 0 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 G5303 J 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 G5304 K 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 0 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 G5305, G5306 L 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 G5313, G5314 M 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 G5318 N 2 2 0 2 2 2 2 0 2 2 2 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 0 G5323 a PATS types are designated arbitrarily with different letters. Prefixes of each PATS primer pair A/B and virulence gene primer pair F/R are indicated. 0, no amplicon; 1, amplicon without Xba I site; 2, amplicon with Xb site. PATS primer pairs producing polymoφhic results between strains are shown in bold. c Isolates of E. coli 0157:H7 from various outbreaks (see Table 3) that fell within a given PATS type. Phylogenetic analysis of PATS profiles suggests a clonal lineage for E. coli O157:H7 isolates. Based on the PATS profiles, the 44 E. coli O157:H7 isolates were grouped into four major phylogenetic clusters (Fig. 5A). A genetic distance of <0J between each cluster was suggestive of clonal relatedness. A closer analysis ofthe paired isolates from each outbreak was carried out. The PATS profile type was identical for the two isolates from 16 ofthe 22 outbreaks; as an example, isolates G5321 and G5322 belonging to outbreak number 3, shared the PATS profile type Ε (Tables 3 and 5; Fig. 5A). Isolates from five additional outbreaks (outbreaks 7, 13, 14, 16, and 22) had highly related PATS types, with only one polymoφhism between the paired-isolates; for instance, isolates G5303 and G5304, belonging to outbreak 16, had the PATS profile types I and J respectively, differing only by the IK8 fragment polymoφhism (Tables 3 and 5; Fig. 5A). The remaining two isolates, G5323 and G5326 from outbreak 2, were different due to multiple polymoφhisms (Tables 3 and 5; Fig. 5 A); these isolates also had substantially different PFGΕ patterns (Fig. 6) and so may not, in fact, be related isolates. Overall, the PATS typing system was able to correctly relate pairs of isolates from an outbreak for at least 21 ofthe 22 outbreaks (95%) tested (100% if isolates G5323 and G5326 are excluded). Some isolates from different outbreaks shared a common PATS type, leading to the larger clusters seen in the dendrogram (Fig. 5 A), further supporting the clonal descent of these isolates. PFGΕ, the most commonly used current standard for typing E. coli O157-.H7, was also used to categorize the 44 isolates from the CDC (Fig. 6). The PATS dendrogram was compared with the PFGΕ dendrogram for the isolates in order to evaluate the potential of these two techniques in relating/discriminating outbreak-associated E. coli O157:H7. Phylogenetic analysis based on PFGΕ profiles resolved the 44 CDC isolates into smaller clusters with greater genetic distance between them than PATS. PFGΕ identified pairs from six outbreaks (outbreaks 3, 7, 10, 11, 15, and 16) as identical. For example, isolates G5321 and G5322 from outbreak 3 shared the same PFGΕ pattern (Table 3, Figs. 5B and 6). Sixteen isolates from eight outbreaks (outbreaks 4, 5, 9, 12, 13, 14, 18, and 21) were classified as probably related (differences of 1 - 3 bands), as defined by Tenover et al (J. Clin. Microbiol. 33, 2233-2239 (1995)). For instance, the PFGE patterns of isolates G5317 and G5318, from outbreak 13, differed by one band (Table 3, Figs. 5B and 6). Ten isolates from five outbreaks (outbreaks 1, 2, 6, 19, and 22) were possibly related (differences of 4 - 6 bands). For example, isolates G5320 and G5327 from outbreak 1 differed by four bands in the PFGE pattern (Table 3, Figs. 5B and 6). Six isolates from three outbreaks (outbreaks 8, 17, and 20) were untypeable by PFGE (a common problem in PFGE typing) (Table 3, Figs. 5B and 6). These six isolates were all typeable by PATS and fell into a distinctive cluster (cluster I on Fig. 5A). PFGE was more discriminatory than PATS, with no overlaps in patterns between different outbreaks. However, PFGE matched fewer E. coli O157:H7 within outbreaks (pairs from 14 of 22 outbreaks were classified as identical or probably related) and was unable to type six isolates, thereby increasing the complexity of inteφretation. In contrast, PATS typed all 44 isolates and matched 21 of 22 outbreak pairs as identical or related. DNA dot blots can effectively detect PATS amplicons. A dot blot assay to detect PATS amplicons was developed, to assess the feasibility of automating the PATS typing system. Eight PATS primer pairs that amplified polymoφhic regions in the 0157 genome were selected for the assay, as these were critical to the discriminatory power of PATS (Tables 4 and 5). Using these primer pairs, target-amplicons were derived from E. coli O157:H7 strain 86-24 or 933 and were spotted on nylon filters. Multiplex PCR was utilized to synthesize the probe amplicons to further expedite the assay. Ofthe eight primer pairs, seven were successfully used in a multiplex reaction. Primer pair IKB5A B failed to produce sufficient quantities of its amplicon when used in combination with the other seven primer pairs, irrespective ofthe template. Altering the primer concentrations, template concentrations, annealing temperatures, extension times, number of cycles and various additives did not alter the performance of IKB5A/B. Hence, the probe-amplicon from this primer pair was synthesized in a separate single primer pair PCR and subsequently purified, labeled and pooled with the rest ofthe probe-amplicons. Dot blots of target-amplicons were hybridized with the probe-amplicons tagged with a chemiluminescent label. Resulting hybridization patterns correlated precisely with the PATS profiles for the respective isolates (Fig. 7, Table 5). This study describes a novel E. coli O157:H7 typing system that utilizes a technique termed PATS, which is based on the presence or absence of specific DNA segments in genomic DNA. The technique is simple, highly reproducible and allows accurate objective inteφretation of results. Typing of pathogenic bacterial strains is important since distinct clones within a species/serotype may be associated with disease outbreaks and the severity and frequency of infection (Musser, Emerg. Infect. Dis. 2, 1-17 (1996)). Contemporary molecular typing techniques in use are based on restriction fragment length polymoφhisms or distribution of random short sequence repeats (Olive and Bean, J. Clin. Microbiol. 37, 1661-1669 (1999); van Belkum et al., Curr. Opin. Microbiol 2, 306-311(1999)). Of these, PFGΕ is considered to be the "gold standard" for typing, as it generates distinctive profiles that distinguish strains in several serotypes and species, including E. coli O157:H7 (Barrett et al, J. Clin. Microbiol. 32, 3013-3017 (1994); Bohm and Karch, . Clin. Microbiol. 30, 2169-2172 (1992); Olive and Bean, J. Clin. Microbiol. 37, 1661- 1669 (1999)). Since the Xbal restriction enzyme site occurs infrequently in the O157:H7 genome, it is frequently used with PFGΕ for this organism (Barrett et al, J. Clin. Microbiol. 32, 3013-3017 (1994); Bohm and Karch, J. Clin. Microbiol. 30, 2169-2172 (1992); Harsono et al., Appl. Environ. Microbiol. 59,3141-3144 (1993)). Although PFGΕ has been successfully used to support outbreak investigations, the technique has its limitations. For example, it may be impossible to fully resolve all bands on a gel under a single set of conditions, making inteφretation and comparisons difficult (Harsono et al, Appl. Environ. Microbiol. 59,3141-3144 (1993); Johnson et al, Appl. Environ. Microbiol 61,2806-2808 (1995); Meng et al, J. Med. Microbiol. 42,258-263 (1995)). To overcome problems associated with present typing systems, a different typing methodology was developed, which has been termed PATS, based on detecting the presence or absence ofthe DNA segments containing the polymoφhic Xbal sites. PFGΕ usually resolves about 20-25 Jibuti-digested fragments for most E. coli O157:H7 isolates (smaller Xbal fragments are not visualized by PFGΕ) (Barrett et al, J. Clin. Microbiol. 32, 3013-3017 (1994); Harsono et al, Appl. Environ. Microbiol. 59,3141-3144 (1993); Meng et al, J. Med. Microbiol. 42,258-263 (1995)). A total of 40 Xbal sites between the genomes of two E. coli O157:H7 reference strains were identified, and eight of these 40 DNA segments were shown to be present or absent across a large collection of 0157 strains. Reproducibility of PATS was demonstrated by consistency of typing patterns over three repeat PCRs. Compared to PFGΕ, PATS typed every E. coli O157:H7 isolate tested, matching 21 out of 22 outbreak pairs as identical or related and one pair as different. Four virulence gene primer pairs into the PATS typing system. Pathogenicity of E. coli O157:H7 is linked to these latter genes and their identification would help detect strains with potential for virulence in humans (Kaper and O'Brien, ASM Press (1998); Paton and Paton J. Clin. Microbiol. 36, 598-602 (1998)). Since the regions amplified by the virulence gene primer pairs lacked Xbal sites, polymoφhisms in these virulence genes were distinguished by the presence or absence of these amplicons. In comparison to PATS, PFGΕ matched fewer E. coli O157:H7 pairs within outbreaks (pairs from 14 of 22 outbreaks were classified as identical or highly related) and was unable to type six isolates, thereby increasing the complexity of inteφretation. Since the outbreak strains tested here were collected between 1982 and 1993, it is possible that non-matching PFGΕ patterns of strains from the same outbreak are due to mutations that occurred during subculturing ofthe isolates. It is also possible that some ofthe isolates were misclassified as being outbreak-related, since subtyping was not available at the time of most ofthe outbreaks. Unlike PFGΕ, methylation of Xbal sites does not interfere with PATS typing as it is a PCR based procedure (Dieffenbach and Dveksler, Cold Spring Harbor Press, (1995)), thereby avoiding this potentially confounding variable. One drawback of PATS was that it was less' discriminatory than PFGΕ. While PATS detects the presence or absence of sequences containing Xbal sites, PFGΕ is also sensitive to insertions/deletions that may occur between Xbal sites, changing the size ofthe intervening fragment without altering the Xbal sites themselves. Also, two ofthe Xbal sites used in the PATS procedure are in DNA segments duplicated elsewhere in the genome (data not shown). While PATS is not dicriminate this duplication (it cannot distinguish between one or two copies of identical DNA segments in a genome), such duplications can affect the PFGE pattern. Although PATS was less discriminatory in our study than PFGE, the precision ofthe PATS procedure would be enhanced by identifying additional insertions/deletions in O157:H7 isolates and designing corresponding PATS primers. PATS is a particularly powerful epidemiological tool for typing E. coli O157:H7 and other bacteria, even when compared to recently introduced typing techniques, such as MLST and octamer-based genome scanning (OBGS) (Kim et al, Proc. Natl. Acad. Sci. U.S.A. 96, 13288-13293 (1999)). While MLST can provide unambiguous results that are widely accessible over websites, the need for sequencing each isolate may not be cost-effective or provide rapid results (Feil et al, Mol Biol Evol. 16, 1496-1502 (1999)). The OBGS technique is similar to enterobacterial repetitive intergenic consensus sequence-PCR (Olive and Bean, J. Clin. Microbiol 37, 1661-1669 (1999)) and has the inherent disadvantage of relying on repeat sequences; short sequence repeats are apt to undergo variation in composition and position through slipped strand nώpairing during DNA replication and hence, techniques based on these repeats should be used with caution (van Belkum et al, Microbiol. Mol Biol. Rev. 62, 275-293 (1998); van Belkum Curr. Opin. Microbiol. 2, 306-311 (1999)). Most importantly, as with PFGE, multiple DNA fragments generated by OBGS require elecfrophoretic separation and inteφretation using special software (Kim et al, Proc. Natl. Acad. Sci. U.S.A. 96, 13288-13293 (1999)). Automation according to standard methods would further enhance the applicability of PATS for routine typing of bacterial isolates. The concordance ofthe results ofthe DNA dot blot with the results by agarose gel electrophoresis suggests that a variety of techniques including the use of DNA microarrays are useful for such automation ofthe PATS typing system. Detailed Materials and Methods Described below are detailed materials and methods relating to the above-described experimental showing that polymoφhic amplified typing sequences provide an approach to E. coli O157:H7 strain typing. Bacteria, plasmids and media used in this study. (i) E. coli O157:H7: Two strains of E. coli O157:H7 were used in the standardization of PATS. Strain 86-24, streptomycin resistant and originally isolated from a human in a Washington State outbreak, was obtained from Dr. A. D. O'Brien (Table 3). Strain 933, a human isolate from a Michigan State outbreak, was obtained from the American Type Culture Collection (ATCC, Manassas, Na.) which has it banked as ATCC 43895 (Table 3) (Wells et al, J. Clin. Microbiol 18, 512-520 (1983)). Strain 933 is the E. coli O157:H7 isolate sequenced at the University of Wisconsin-Madison, Madison, WI (Perna et al, 2001). In addition, 44 isolates of E. coli O157:H7, two each from 22 different outbreaks, were obtained from the Centers for Disease Control and Prevention (CDC), Atlanta, Ga. The CDC numbers assigned to these isolates and the outbreaks they were associated with are indicated in Table 3. These isolates were primarily human isolates with the exception of two; G5308 was isolated from garden manure and G5310 from meat. (ii) Other E. coli and plasmids: E. coli DH5α (F _ endAl hsdRl 7 supE44 thi-1 recAl gyrA96 relAl A(argF-lacZYA)Ul 69 (Φ80d /αcZΔM15)) was used as the host strain to propagate recombinant plasmids. The plasmid pBluescribe (Stratagene USA, LaJolla, Ca.) was used as the cloning vector. (iii) Media: All E. coli O157:H7 were grown in Luria-Bertani (LB) media. A single colony from each isolate was used to prepare -80°C stocks in LB broth with 15% glycerol. DΝA extraction, sequencing, and probe labeling. Genomic DΝA was prepared using the Invitrogen Εasy-DΝA Isolation kit (Invitrogen Coφoration, Carlsbad, Ca.) as per the manufacturer's instructions. Plasmid DΝA was extracted using Qiagen plasmid purification kits (Qiagen Inc., Valencia, Ca.). Standard spectrophotometric analysis and agarose gel electrophoresis techniques were used to quantitate and evaluate purity of all DNA prepared (Ausubel et al, Current Protocols In Molecular Biology. New York: John Wiley and Sons, Inc.(1993); Maniatis, Fritsch, and Sambrook, Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Laboratory (1989)). DNA sequencing was done at the DNA Sequencing Core Facility, Department of Molecular Biology, Massachusetts General Hospital. This facility uses ABI Prism DiTerminator cycle sequencing with AmpliTaq DNA polymerase FS and an ABI 377 DNA sequencer (Perkin-Elmer Applied Biosystems Division, Foster City, Ca.) for this puφose. All DNA probes were labeled using the ECL direct nucleic acid labeling and detection system (Amersham Pharmacia Biotech, Inc., Piscataway, NJ.). This approach is based on the direct labeling of DNA probes with horseradish peroxidase and detection by light generation resulting from the enzymatic cleavage of a chemiluminescent substrate, luminol. Identification of genomic DNA fragments in E. coli O157:H7 containing an Xbal restriction site. (i) From Sαw3AI-digested genomic DNA of E. coli O157:H7 strain 86-24 (Fig. 3): Genomic DNA from strain 86-24 was digested to completion using the restriction enzyme SauiΛl (New England Biolabs, Inc., Beverly, Ma.). The digested fragments were allowed to self-ligate overnight and the circularized DNA then digested with ϊbαl (New England Biolabs); this ensured that only fragments containing an internal Xbal restriction site would linearize. The linearized fragments were cloned into the Xbal site in the multiple cloning site of pBluescribe. The resulting recombinant plasmids are prefixed as pIK. Plasmids were elecfroporated into competent E. coli DH5α cells using standard protocols (Maniatis et al, Cold Spring Harbor Laboratory (1989)). Transformants were screened on LB plates supplemented with ampicillin (100 μg/ml; Sigma Chemical Co., St. Louis, Mo.), 5-bromo-4-chloro-3-indolyl-β-D- galactopyranoside (X-Gal; 40 μg/ml; Sigma) and isopropyl-β-D- thiogalactopyranoside (IPTG; 1 mM; Sigma). A total of 100 white E. coli DH5α colonies containing recombinant plasmids were selected for further testing. Each strain containing a recombinant plasmid is prefixed IK in this paper. (ii) From NMII-digested genomic DΝA of E. coli O157:H7 strain 933 (Fig. 3): A different strain was used to recover Nlalϊl fragments of genomic DΝA containing Xbal sites, in order to increase the diversity of Xbal sites identified, including those not recovered in Sau3AI fragments above. Genomic DΝA from strain 933 was digested to completion using the restriction enzyme NlaUl (New England Biolabs). Subsequent steps leading to the selection of - bαl-containing fragments and the final screening of recombinant clones were as above. A total of 50 white E. coli DH5α colonies containing recombinant plasmids were selected for further testing. Plasmids and colonies were named as indicated above. (iii) From E. coli O157:H7 strain 933 genomic DNA sequence: A total of 40 Xbal sites were localized in the 933 genomic sequence assembled at the University of Wisconsin-Madison, Madison, WI, of which two were in duplicated regions and were not included in this study. Ofthe remaining 38 Xbal sites, 20 were already identified in plasmids described above, and 18 were newly identified from the genome sequence. The sequences surrounding these IS Xbal sites are referred to with the prefix 1KB in this paper. Two additional Xbal- containing genomic segments are unique to strain 86-24 and were recovered in step (i) above. Evaluation of recombinant plasmids. Plasmid DNA was extracted from isolated colonies of IKl-150 and plasmids pIKl-150 were screened for the presence of an appropriate insert. As a result ofthe self-ligation at the Sau3AI or NlaUl sites, digestion with Xbal and cloning, an appropriate insert would have Xbal sites at either end, and a single, internal Sau3AI or NlaUl site (Fig. 3). Plasmids were digested with Xbal to check for the release of a single insert. In addition, pBluescribe-specific primers (see below) were used to amplify the insert by PCR. The resulting amplicons were purified using the Qiaquick PCR purification kit (Qiagen, Inc.) and then digested with either Sα«3AI or N JI, to confirm the presence of these sites within the fragments. DΝA fragments were resolved by agarose gel electrophoresis and visualized by staining with ethidium bromide. The pBluescribe-specific primers were in the multiple cloning site on either side of the insert, and were: Reverse (5'-GAAACAGCTATGACC ATG-3'; SEQ ID NO.: 18) and M13 -20 (5'-GTAAAACGACGGCCAGT-3'; SEQ ID NO.19). PCR was done on a PTC-100 thermal cycler (MJ Research, Inc., Watertown, Ma.), using 10 ng plasmid DNA, 100 pmoles of each vector primer, 800 μM dNTPs, lx diluted Ex Taq™ enzyme buffer and 2.5 units of TaKaRa Ex Taq™ DNA polymerase (Takara Shuzo Co., LTD., Panvera Coφoration, Madison, Wi.). Denaturation at 95°C for 5 min was followed by 30 cycles of amplification (1 min at 95°C, 1 min at 45°C, 1 min at 72°C per cycle) and a final extension at 72°C for 1 min. Each reaction was done in triplicate. As more recombinant plasmids were studied, duplicates containing inserts already analyzed were eliminated using Southern blot hybridization. Briefly, -Ybαl-digested plasmid DNA was electrophoresed on an agarose gel, transferred to Hybond-N+ membranes (Amersham Pharmacia), UN. crosslinked to the membrane using a Stratalinker (Stratagene), and hybridized with a pool of the previously characterized insert DΝAs labeled as described above. Hybridization at 42°C and post-hybridization washing of blots was done as per the ECL kit manual (Amersham Pharmacia). Autoradiographs were prepared by exposure of processed blots to the Kodak Scientific Imaging X-OMAT AR film (Eastman Kodak Company, Rochester, ΝY.), and plasmids containing inserts hybridizing to the pool of previous inserts were not further evaluated. Design of PATS and virulence gene primer pairs. Plasmids with appropriate inserts were sequenced using pBluescribe specific primers (reverse and M13 -20). Insert sequences were used to design PATS primer pairs flanking each Xbal site on the genome and designed to amplify fragments of approximately 200-400 bp (Fig. 3). In the context ofthe plasmid, these primers appear divergent to each other, since the genomic Xbal site is linearized at either end ofthe insert (Fig. 3). However, in the undigested genome, each primer pair flanks a single, internal Xbal site. PATS primer pairs were also designed to amplify the 18 Xbal sites specifically identified from the E. coli O157:H7 strain 933 genome sequence. Primer pairs were also generated to amplify specific virulence genes found in strains of E. coli O157:H7, similar to those designed by Paton et al (Paton and Paton, J. Clin. Microbiol. 36, 598-602 (1998)). The four primer pairs included: stx x V (5'-ATAAATCGCCATTCGTTGACTAC-3'; SΕQ ID NO:20) / stx x R (5'-GAACGCCCACTGAGATCAT C-3';SΕQ ID NO:21), st&Y (5'- GGCACTGTCTGAAACTGCTCC-3'; SEQ ID NO:22) / st^-R (5'- TCGCCAGTTATCTGACAT TCTG-3'; SEQ ID NO:23), eaeF (5'- GACCCGGCACAAGCATA AGC-3'; SEQ ID NO:24) / eαeR (5'- CCACCTGCAGCAA CAAGAGG-3';SEQ ID NO:25) and hlvAY (5'- GCATCATCAAGCGT ACGTTCC-3'; SEQ ID NO:26) / hlyAR (5'- AATGAGC CAAGCTGGTTAAGCT-3'; SEQ ID NO:27). PATS typing. PATS primers were used to assay for the presence or absence of individual Xbal sites in different isolates of E. coli O157:H7. PCR was done using E. coli O157:H7 colony lysate and /or genomic DNA as templates. Colony lysates were prepared by boiling a suspension of colonies in sterile distilled water, followed by centrifugation at 4°C. Each E. coli O157:H7 isolate template was tested with each individual PATS primer pair, in separate reactions. PCR was done on the GeneAmp PCR system 2400 thermal cycler (PE Biosystems, Foster City, Ca.), using 200 ng genomic DNA or 10 μl of colony lysate, 200 pmoles of each PATS primer, 800 μM dNTPs, lx diluted Ex Taq™ enzyme buffer and 2.5 units of TaKaRa Ex Taq™ DNA polymerase. Hot start PCR technique was employed in which the polymerase was added only after preheating the rest ofthe PCR mix (Dieffenbach and Dveksler, Cold Spring Harbor Press (1995)). This technique was used in combination with a Touchdown PCR profile (Lawrence and Hartl, Genetica 84, 23-29 (1991)). To create this profile, the regular PCR program was modified as follows: an amplification segment of 20 cycles was set where the annealing temperature started at 73°C, to touchdown at 53°C at the end of those cycles. Then, another amplification segment of 10 cycles was set, using the last annealing temperature of 53°C. Each reaction was done in triplicate. Amplicons obtained by PCR were purified using the Qiaquick PCR purification kit and digested with.-¥bαl to confirm the presence of an Xbal site within the amplicon. Undigested and digested DNA fragments were resolved on a 4% agarose gel prepared with a combination of 3% Nusieve GTG agarose (FMC BioProducts, Rockland, Me) and 1% agarose (Shelton Scientific Inc., Shelton, Ct), stained with ethidium bromide. These same amplicons were also used to probe genomic DNA of isolates used in PATS typing, following digestion with Sau3 Al. Pulsed-field gel electrophoresis (PFGE). PFGE analysis of all E. coli O157:H7 isolates was done at the CDC, Atlanta, Georgia. Standard procedures previously described (Ausubel et al, Current Proocols in Moelcular Biology, John Wiley and Sons, Inc. (1993); Barrett et al, J. Clin. Microbiol. 32, 3013-3017 (1994)) were used, with the following modifications. Briefly, genomic DNA of each isolate was embedded in separate agarose plugs and digested at 37°C for 2 hr with 30U of Xbal per plug (Gibco BRL, Grand Island, N.Y.). The plugs were loaded onto a 1% agarose-Tris buffer gel (SeaKem Gold Agarose, BioWhittaker Molecular Applications, Rockland, Ma.) and PFGE was performed using a CHEF Mapper XA (Bio-Rad Laboratories, Hercules, Ca.). DNA was electrophoresed for 18 h at a constant voltage of 200 V (6 V/cm), with a pulse time of 2.2 to 54.2 s, an electric field angle of 120°, and temperature of 14°C, before being stained with ethidium bromide. DNA dot-blots. Primer pairs IK8A/B, IK25A B, IKl 14A/B, IKl 18A/B, IK123A/B, IK127A B, IKB3A/B, and IKB5A/B were used in this assay. Amplicons were first obtained from E. coli O157:H7 strain 86-24 or 933, using each primer pair in a separate reaction. 2.5 μl of each purified amplicon was spotted on Hybond N+ membrane (Amersham Pharmacia) strips and UN. crosslinked; these constituted the "target-amplicons". TenE. coli O157:H7 isolates (G5301, G5302, G5295, G5296, G5323, G5326, G5313, G5314, G5303, and G5304), from five different outbreaks, were selected for analysis by dot-blot using multiplex PCR. For each of these isolates, amplicons were derived using seven ofthe eight primer pairs in a multiplex PCR reaction, as well as a separate PCR reaction for primer pair IKB5A B. To ensure equal quantities of all amplicons in the multiplex reaction, primer concentrations were varied. Primer pairs IK25A/B, IK114A/B, IK123A B, and IK127A B were used at a concentration of 200 pmoles per primer; primer pairs IK8A/B, IKl 18A/B, and IKB3 A/B were used at 100 pmoles per primer. In the separate PCR reaction, primer pair IKB5A/B was used at a concentration of 200 pmoles per primer. These amplicons were purified, labeled with the ECL kit and pooled; these constituted the "probe-amplicons". Each membrane strip containing the target-amplicons was hybridized at 42°C with the pool of purified probe-amplicons generated from a single isolate and autoradiographs prepared by exposure of processed blots to the Kodak Scientific Imaging X-OMAT AR film (Eastman Kodak Company), to detect the presence or absence of hybridizing amplicons in the isolates being analyzed. Software. PFGE gels were analyzed using Molecular Analyst Fingeφrinting Plus software (Bio-Rad). Dendrograms were constructed using the unweighted pair- group method with arithmetic mean (UPGMA). Other Embodiments All publications and patent applications mentioned in this specification are herein incoφorated by reference to the same extent as if each independent publication or patent application was specifically and individually indicated to be incoφorated by reference. We claim:

Claims: Claims 1. A method for typing the strain of a bacterial isolate, said method comprising the steps of: (a) providing genomic DNA from a bacterial isolate; (b) performing a polymerase chain reaction on the genomic DNA using a first and second primer to amplify genomic DNA comprising a restriction nuclease restriction site, thereby producing an amplicon having the restriction site; and (c) characterizing the amplicon of step (b), thereby typing the strain of the bacterial isolate. 2. The method of claim 1 , further comprising performing a polymerase chain reaction on genomic DNA of a reference strain of a bacterial isolate using the first and second primers of step (b) to amplify genomic DNA of the reference strain ofthe bacterial isolate, and wherein step (c) is carried out by characterizing the amplicon ofthe reference strain ofthe bacterial isolate with the amplicon of step (b). 3. The method of claim 2, wherein said reference strain of the bacterial isolate is E. coli O157:H7 strain 86-24. 4. The method of claim 1 , further comprising digesting the amplicon of step (b) with a restriction nuclease that digests the amplicon at the restriction site and where step (c) is carried out by charactering the digestion products. 5. The method of claim 4, further comprising performing a polymerase chain reaction on genomic DNA of a reference strain of a bacterial isolate using the first and second primers of step (b) to amplify genomic DNA of the reference strain ofthe bacterial isolate and digesting said amplicon ofthe reference strain with the restriction nuclease, and where step (c) is carried out by characterizing the digestion products ofthe cleaved amplicon. 6. The method of claim 5, wherein said reference strain ofthe bacterial isolate is E. coli O157:H7 strain 86-24. 7. The method of claim 2, wherein said restriction site occurs infrequently in the genome ofthe bacterial isolate. 8. The method of claim 7, wherein said restriction nuclease cleaves rarely within the genome ofthe bacterial isolate. 9. The method of claim 8, wherein said restriction nuclease is Xbal. 10. The method of claim 1 , wherein said amplicon of step (b) comprises at least 200-400 bp. 11. The method of claim 1 , wherein said strain of the bacterial isolate is a pathogenic strain. 12. The method of claim 1, wherein said strain is a strain of E. coli O157.H7. 13. A method for identifying a pair of primers for typing a bacterial strain, said method comprising the steps of: (a) providing genomic DNA of a bacterial strain; (b) digesting the genomic DNA ofthe bacterial strain with a restriction nuclease that cleaves a restriction site ofthe genome ofthe strain, said restriction site being flanked by a 5 ' and 3 ' region of DNA; (c) identifying a first primer that hybridizes to the 5 ' region flanking the restriction site and a second primer that hybridizes to the 3' region ofthe restriction site, wherein said first and second primers amplify genomic DNA of the bacterial strain having the restriction site; (d) performing a polymerase chain reaction (PCR) on the genomic DNA ofthe bacterial strain using the first and second primers of step (c) to amplify genomic DNA ofthe bacterial strain, thereby producing an amplicon; (e) providing a second genomic DNA, the second genomic DNA being from a reference bacterial strain, (f) performing a polymerase chain reaction (PCR) on the reference genomic DNA using the first and second primers of step (c) to amplify genomic DNA ofthe reference bacterial strain, thereby producing an amplicon; (i) comparing the amplicons of step (d) and step (f), wherein a difference between the amplicons of steps (d) and (f) identifies the pair of primers as a pair of primers for typing the bacterial strain. 14. The method of claim 13, further comprising digesting the amplicons of step (d) and step (f) with a restriction nuclease that cleaves the amplicons at the restriction site, and further comparing the digested amplicons of step (d) and (f), wherein a difference between the products ofthe digested amplicons of steps (d) and (f) further identifies the pair of primers for typing the bacterial strain. 15. The method of claim 13, wherein said restriction site occurs infrequently in the genome ofthe bacterial strain. 16. The method of claim 13, wherein said restriction nuclease cleaves rarely wimin the genome ofthe bacterial strain. 17. The method of claim 13, wherein said restriction nuclease is Xbal. 18. The method of claim 13, wherein said amplicon of step (c) comprises at least 200-400 bp. 19. The method of claim 13, wherein said bacterial strain is a pathogenic strain. 20. The method of claim 19, wherein said pathogenic bacterial strain is E. coli Ol 57.H7. 21. The method of claim 13, wherein said the reference strain of step (e) comprises a bacterial strain is E. coli O157:H7. 22. The method of claim 21, wherein said reference strain is E. coli O157:H7 strain 86-24. 23. A kit for distinguishing between bacterial strains comprising a set of primer pairs which, when used in a PCR reaction of genomic DNA from a sample of a bacterial isolate amplify DNA across a site for a restriction endonuclease, the amplified DNA being polymoφhic between strains ofthe bacteria. 24. The kit of claim 23, wherein said kit includes a set of primers identified according to the method of claim 13. 25. The kit of claim 23, said kit comprising primers for identifying a pathogenic bacterial strain. 26. The kit of claim 25, wherein said strain is a strain of E. coli O157.H7. 27. A bacterial strain typing profile, said typing profile produced according to the method of claim 1. 28. The typing profile of claim 27, wherein said profile is depicted on an agarose gel. 29. The typing profile of claim 27, wherein said profile is depicted on a dot blot.

Inventors: AUSUBEL FREDERICK M, CALDERWOOD STEPHEN B, KUDVA INDIRA, AUSUBEL, FREDERICK, M., CALDERWOOD, STEPHEN, B., KUDVA, INDIRA
Applicants: AUSUBEL FREDERICK M, CALDERWOOD STEPHEN B, GEN HOSPITAL CORP, KUDVA INDIRA, AUSUBEL, FREDERICK, M., CALDERWOOD, STEPHEN, B., KUDVA, INDIRA, THE GENERAL HOSPITAL CORPORATION
Application year: 2001
Main classification: C12Q1
IPC codes: C12Q1